Icotyde (icotrokinra) has been approved by the US FDA to treat moderate-to-severe plaque psoriasis (PsO) in both adults and ...

AL-S Pharma has released new data from the phase 2 trial evaluating its drug AP-101 in patients with amyotrophic lateral sclerosis (ALS). ALS is a progressive neurodegenerative disease that affects ...

Envision Pharma Group (Envision) has appointed Darren Coleman as Executive Vice President, Chief Information Officer. Coleman ...

Envision Pharma Group (Envision) has appointed Jay Ferro as President, Technology and Chief Product Officer (CPO). He joins ...

Richmond Pharmacology has appointed John Hotti as Chief Technology Officer (CTO), strengthening the company’s leadership in technology-enabled clinical research. Hotti brings over 35 years of global ...

Grifols have announced proof-of-concept data from its Chronos-PD programme, which uses AI, advanced proteomics and real-world ...

Shionogi has dosed the first patients in the phase 2 clinical trial evaluating S-606001, a potential treatment for late-onset ...

Bladder cancer affects over 224,000 people annually in Europe, with over 30% of cases being muscle-invasive bladder cancer ...

Raguneprocel, a stem cell-based dopamine neuron replacement therapy for treating motor symptoms in Parkinson’s disease (PD), ...

Clasado Biosciences has appointed Sebastian Nummelin as APAC Regional Director. The move strengthens its commercial presence ...